Drug intelligence / Profile preview

echinacoside

Development stage
Phase 1
Modality
Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral, Topical, Intravenous
01

Overview

Echinacoside is a natural phenylethanoid glycoside first isolated from Echinacea angustifolia. It is currently being investigated for its anti-apoptotic, neuroprotective, antioxidant, anti-inflammatory, and cardiovascular effects. Preclinical studies suggest potential therapeutic applications in neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease, as well as atherosclerosis, osteoporosis, acute colitis, wound healing, hepatitis, and certain cancers including endometrial cancer. Mechanistically, echinacoside has been shown to inhibit apoptosis and may exert its effects through modulation of the PI3K/Akt signaling pathway among others[1][4][6]. However, it suffers from poor bioavailability in its prototype form and lacks robust clinical trial evidence for any indication.

Brand names
Naoqingzhiming
Other names
ECH
02

Targets

MMP9 (Matrix metalloproteinase-9)HSP90AA1 (Heat shock protein HSP90-alpha)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)CASP3 (Caspase-3)ESR1 (ERα)

Beyond the preview

Go deeper on echinacoside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on echinacoside.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call